Sinocare Inc. (SHE: 300298)

Market Cap	13.62B
Revenue (ttm)	4.18B
Net Income (ttm)	306.51M
Shares Out	553.84M
EPS (ttm)	0.55
PE Ratio	44.60
Forward PE	32.02
Dividend	0.20 (0.81%)
Ex-Dividend Date	Jun 17, 2024

Volume	1,602,416
Open	24.80
Previous Close	24.60
Day's Range	24.40 - 25.29
52-Week Range	19.19 - 33.28
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It als...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 4,531
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2023, Sinocare's revenue was 4.06 billion, an increase of 2.69% compared to the previous year's 3.95 billion. Earnings were 284.40 million, a decrease of -36.31%.